That's interesting. I am curious, what kind of analyses did you work with on the molecule and drug itself? Was it like mostly reading papers/patents or did your team do anything experimental?
Nothing experimental. Only using foundational models. And usually basic stuff thats more relevant to the indication we were looking ie does it cross the bbb or potency models